SCM
CDIOW icon

Saba Capital Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Saba Capital Management’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.16K Hold
199,839
– – ﹤0.01% 373
2025
Q4 		$4.78K Hold
199,839
– – ﹤0.01% 324
2025
Q3 		$4.09K Hold
199,839
– – ﹤0.01% 306
2025
Q2 		$3K Hold
199,839
– – ﹤0.01% 304
2025
Q1 		$7.01K Hold
199,839
– – ﹤0.01% 235
2024
Q4 		$16.6K Hold
199,839
– – ﹤0.01% 230
2024
Q3 		$7.77K Hold
199,839
– – ﹤0.01% 294
2024
Q2 		$7.18K Hold
199,839
– – ﹤0.01% 328
2024
Q1 		$21.3K Hold
199,839
– – ﹤0.01% 304
2023
Q4 		$34.8K Hold
199,839
– – ﹤0.01% 344
2023
Q3 		$8.2K Hold
199,839
– – ﹤0.01% 508
2023
Q2 		$37.7K Hold
199,839
– – ﹤0.01% 437
2023
Q1 		$63.9K Sell
199,839
-35,758
-15% -$8.39K ﹤0.01% 523
2022
Q4 		$11.7K Hold
235,597
– – ﹤0.01% 789
2022
Q3 		$39K Hold
235,597
– – ﹤0.01% 875
2022
Q2 		$31K Hold
235,597
– – ﹤0.01% 955
2022
Q1 		$46K Buy
+235,597
New +$56K ﹤0.01% 875

Other funds holding CDIOW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Saba Capital Management's CDIOW Position: Q1 2026 in Review

Saba Capital Management held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q1 2026 at 199,839 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

Saba Capital Management first reported a position in CDIOW in Q1 2022 and has held it in 17 quarters since. The position peaked at $63.9K in Q1 2023. 7 funds tracked by Wall St. Rank hold CDIOW as of Q1 2026.

  • Saba Capital Management held 199,839 shares of Cardio Diagnostics Holdings Inc Warrant worth $3.16K as of Q1 2026.
  • Saba Capital Management left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q1 2026.
  • Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of Saba Capital Management's portfolio in Q1 2026, its #373 holding.
  • Saba Capital Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and has held it in 17 quarters since.
  • Saba Capital Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $63.9K in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2026.

Based on Saba Capital Management's 13F filing for Q1 2026, filed 15 May 2026.